AIMS: Studies indicate a poorer quality of life (QoL) for implantable cardioverter defibrillator (ICD) patients than for the general population. However, studies comparing the QoL of ICD patients with that of patients with other implantable cardiac devices are scarce. We hypothesized that ICD patients had a poorer QoL than pacemaker patients. METHODS AND RESULTS: All ICD patients living in Iceland at the beginning of 2002 (44 subjects), and a comparison group of 81 randomly selected patients with pacemakers were invited to participate. The Icelandic Quality of Life Questionnaire (IQL), the General Health Questionnaire (GHQ), the Beck Anxiety Inventory (BAI), and the Beck Depression Inventory (BDI) were submitted to measure QoL, psychiatric distress, and symptoms of anxiety and depression. The ICD and pacemaker groups did not differ on IQL, BAI, BDI, or GHQ scores. ICD patients were as a group more fearful of death (P = 0.056) and showed more concerns about returning to work (P = 0.072), although these items fell just short of statistical significance. CONCLUSION: Contrary to our expectations, ICD patients had a comparable QoL with pacemaker recipients and were not more likely to suffer from anxiety, depression, or general psychiatric distress. These findings are encouraging in view of expanding ICD indications.
AIMS: Studies indicate a poorer quality of life (QoL) for implantable cardioverter defibrillator (ICD) patients than for the general population. However, studies comparing the QoL of ICDpatients with that of patients with other implantable cardiac devices are scarce. We hypothesized that ICDpatients had a poorer QoL than pacemaker patients. METHODS AND RESULTS: All ICDpatients living in Iceland at the beginning of 2002 (44 subjects), and a comparison group of 81 randomly selected patients with pacemakers were invited to participate. The Icelandic Quality of Life Questionnaire (IQL), the General Health Questionnaire (GHQ), the Beck Anxiety Inventory (BAI), and the Beck Depression Inventory (BDI) were submitted to measure QoL, psychiatric distress, and symptoms of anxiety and depression. The ICD and pacemaker groups did not differ on IQL, BAI, BDI, or GHQ scores. ICDpatients were as a group more fearful of death (P = 0.056) and showed more concerns about returning to work (P = 0.072), although these items fell just short of statistical significance. CONCLUSION: Contrary to our expectations, ICDpatients had a comparable QoL with pacemaker recipients and were not more likely to suffer from anxiety, depression, or general psychiatric distress. These findings are encouraging in view of expanding ICD indications.
Authors: Ana Claudia C de Ornelas Maia; Gastão Soares-Filho; Valeska Pereira; Antonio Egidio Nardi; Adriana Cardoso Silva Journal: Prim Care Companion CNS Disord Date: 2013-04-18
Authors: Gregory Webster; Kathryn A Panek; Madelyn Labella; George Alexander Taylor; Kimberlee Gauvreau; Frank Cecchin; Maria Martuscello; Edward P Walsh; Charles I Berul; David R DeMaso Journal: Pediatrics Date: 2014-03-24 Impact factor: 7.124
Authors: Lieke M van den Heuvel; Tanya Sarina; Joanna Sweeting; Laura Yeates; Kezia Bates; Catherine Spinks; Catherine O'Donnell; Samuel F Sears; Kevin McGeechan; Christopher Semsarian; Jodie Ingles Journal: Heart Rhythm O2 Date: 2022-02-08
Authors: Daniel Catalan-Matamoros; Antonio Lopez-Villegas; Knut Tore Lappegård; Remedios Lopez-Liria Journal: Int J Environ Res Public Health Date: 2020-10-21 Impact factor: 3.390
Authors: Daniel Catalan-Matamoros; Antonio Lopez-Villegas; Cesar Leal Costa; Rafael Bautista-Mesa; Emilio Robles-Musso; Patricia Rocamora Perez; Remedios Lopez-Liria Journal: PLoS One Date: 2021-12-23 Impact factor: 3.240